Research Solutions Inc
NASDAQ:RSSS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Research Solutions Inc
NASDAQ:RSSS
|
US |
|
X
|
XOMA Corp
F:X0M1
|
US |
|
K
|
KB Home
XMUN:KBH
|
US |
Research Solutions Inc
Research Solutions helps companies and research groups get fast access to scientific papers and other published research. Its main products are software and services that let users search for articles, buy or license them legally, and manage how research content is shared inside an organization. It also helps customers handle the behind-the-scenes work of finding, delivering, and tracking those documents. Its main customers are pharmaceutical and biotech companies, medical device makers, universities, government labs, and other organizations that rely on scientific literature. Research Solutions makes money through subscriptions to its software and through fees tied to article access, document delivery, and related research-content services. In practice, it sits between the big publishers that own the content and the end users who need it. What makes the business different is that it focuses on the workflow around scientific information, not on producing the research itself. It sells a practical tool that saves researchers time and helps organizations control how they obtain and use published content. That makes it a specialized infrastructure business for the research and life-sciences market.
Research Solutions helps companies and research groups get fast access to scientific papers and other published research. Its main products are software and services that let users search for articles, buy or license them legally, and manage how research content is shared inside an organization. It also helps customers handle the behind-the-scenes work of finding, delivering, and tracking those documents.
Its main customers are pharmaceutical and biotech companies, medical device makers, universities, government labs, and other organizations that rely on scientific literature. Research Solutions makes money through subscriptions to its software and through fees tied to article access, document delivery, and related research-content services. In practice, it sits between the big publishers that own the content and the end users who need it.
What makes the business different is that it focuses on the workflow around scientific information, not on producing the research itself. It sells a practical tool that saves researchers time and helps organizations control how they obtain and use published content. That makes it a specialized infrastructure business for the research and life-sciences market.
Top line: Revenue was $12.1 million, down from $12.7 million a year ago, because stronger platform subscription growth was not enough to offset weakness in the lower-margin transactions business.
Profitability: Gross margin improved to 51.7%, net income rose to $860,000, and adjusted EBITDA increased to $1.6 million, showing better earnings even with softer sales.
Churn: Management said churn is still the main drag on growth, but most of the issue is tied to low engagement and weak usage rather than AI-related displacement.
AI push: The company launched two new AI-based MCP products and said it already has more than $1 million in pipeline opportunities tied to them.
B2C trend: B2C showed early improvement, with lower ad spend, better conversion, and improved retention after the MCP launch, helping keep MRR roughly flat quarter over quarter.
Outlook: Management expects Q4 year-over-year improvement in document delivery and wants to exit fiscal 2026 with stronger earnings power and cash generation.
